Key facts today
Eli Lilly's weight-loss drug Zepbound shows over 20% body weight loss, outperforming Novo Nordisk's Wegovy, with weekly prescriptions now exceeding those of Wegovy.
Eli Lilly is testing tirzepatide, the key ingredient in Mounjaro, for its potential to slow kidney disease progression, as part of broader GLP-1 drug studies.
Eli Lilly's lepodisiran, a siRNA drug, cut lipoprotein(a) levels by 94% in six months during a Phase 2 trial, leading to the start of Phase 3 studies.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
11.2 EUR
10.23 B EUR
43.51 B EUR
849.67 M
About Eli Lilly and Company
Sector
Industry
CEO
David A. Ricks
Website
Headquarters
Indianapolis
Founded
1876
FIGI
BBG00PKLKBY1
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
LLY: Potential Bounce Play with 20–30% UpsideLooking for a stock that had strong momentum before but has slowed down over the past year? One that’s now trading near the bottom of its consolidation range, with about a 30% drop from recent highs? LLY fits that description pretty well.
Based on its pattern, it looks like there’s a good chance it
Eli Lilly Stock Down 10.9% Over Past YearTop or Consolidation? Here's My Take...
It's not crystal clear — I can see the case for both. But after years of chart-watching, this doesn't quite look like a top to me:
• Lacks symmetry
• Had chances to break down, but no real follow-through
🧭 Where are we headed?
I think pressure remains, and we
Eli Lillly $LLYNYSE:LLY – Long Setup Ahead of June FOMC
Eli Lilly remains fundamentally strong, with robust growth in revenue (+45% YoY), driven by weight-loss and diabetes drugs like Mounjaro and Zepbound. Despite this, the stock saw a recent pullback after a lowered FY25 profit outlook.
Technical View:
LLY is
LLY - Stock held $720 support next level at $760LLY - Stock back to bouncing off $720 support level on the weekly time frame. Needs to break and hold $760 resistance level for a move towards $800 . Eli Lilly's Zepbound Shows Superior Weight Loss Over Novo Nordisk's Wegovy In Head-To-Head Trial. calls above $760 look good for a move towards $800
Can Lilly Redefine Weight Loss Market Leadership?Eli Lilly is rapidly emerging as a dominant force in the burgeoning weight loss drug market, presenting a significant challenge to incumbent leader Novo Nordisk. Lilly has demonstrated remarkable commercial success despite its key therapy, Zepbound (tirzepatide), entering the market well after Novo
Eli Lilly (LLY) Shares Fall Over 15% in MayEli Lilly (LLY) Shares Fall Over 15% in May
The share price of Eli Lilly and Company (LLY), the world’s largest pharmaceutical company, has seen a sharp shift in market sentiment:
→ From its April low to high, LLY shares rose by over 30%;
→ However, since the start of May, the LLY stock price has
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
LLY4217063
Eli Lilly and Company 2.75% 01-JUN-2025Yield to maturity
25.17%
Maturity date
Jun 1, 2025
LLY.GE
Eli Lilly and Company 7.125% 01-JUN-2025Yield to maturity
10.23%
Maturity date
Jun 1, 2025
XS238628644
ELI LILLY 21/43Yield to maturity
7.92%
Maturity date
Sep 14, 2043
US532457BY3
ELI LILLY 20/50Yield to maturity
7.52%
Maturity date
May 15, 2050
US532457BZ0
ELI LILLY 20/60Yield to maturity
7.36%
Maturity date
Sep 15, 2060
US532457BT4
ELI LILLY 19/49Yield to maturity
6.48%
Maturity date
Mar 15, 2049
US532457BU1
ELI LILLY 19/59Yield to maturity
6.45%
Maturity date
Mar 15, 2059
LLY4217068
Eli Lilly and Company 3.7% 01-MAR-2045Yield to maturity
6.39%
Maturity date
Mar 1, 2045
LLY4492882
Eli Lilly and Company 3.95% 15-MAY-2047Yield to maturity
6.31%
Maturity date
May 15, 2047
US532457BS6
ELI LILLY 19/39Yield to maturity
6.30%
Maturity date
Mar 15, 2039
LLY5547405
Eli Lilly and Company 4.95% 27-FEB-2063Yield to maturity
6.05%
Maturity date
Feb 27, 2063
See all LLYC bonds
Curated watchlists where LLYC is featured.
Related stocks
Frequently Asked Questions
The current price of LLYC is 633.1 EUR — it has decreased by −0.58% in the past 24 hours. Watch ELI LILLY CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange ELI LILLY CO stocks are traded under the ticker LLYC.
LLYC stock has fallen by −3.55% compared to the previous week, the month change is a −18.32% fall, over the last year ELI LILLY CO has showed a −14.76% decrease.
We've gathered analysts' opinions on ELI LILLY CO future price: according to them, LLYC price has a max estimate of 1,050.33 EUR and a min estimate of 595.77 EUR. Watch LLYC chart and read a more detailed ELI LILLY CO stock forecast: see what analysts think of ELI LILLY CO and suggest that you do with its stocks.
LLYC reached its all-time high on Feb 27, 2025 with the price of 887.0 EUR, and its all-time low was 94.9 EUR and was reached on Jul 22, 2019. View more price dynamics on LLYC chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LLYC stock is 1.50% volatile and has beta coefficient of 0.79. Track ELI LILLY CO stock price on the chart and check out the list of the most volatile stocks — is ELI LILLY CO there?
Today ELI LILLY CO has the market capitalization of 603.76 B, it has increased by 0.47% over the last week.
Yes, you can track ELI LILLY CO financials in yearly and quarterly reports right on TradingView.
ELI LILLY CO is going to release the next earnings report on Aug 7, 2025. Keep track of upcoming events with our Earnings Calendar.
LLYC earnings for the last quarter are 3.09 EUR per share, whereas the estimation was 3.01 EUR resulting in a 2.51% surprise. The estimated earnings for the next quarter are 4.90 EUR per share. See more details about ELI LILLY CO earnings.
ELI LILLY CO revenue for the last quarter amounts to 11.77 B EUR, despite the estimated figure of 11.71 B EUR. In the next quarter, revenue is expected to reach 12.70 B EUR.
LLYC net income for the last quarter is 2.55 B EUR, while the quarter before that showed 4.26 B EUR of net income which accounts for −40.12% change. Track more ELI LILLY CO financial stats to get the full picture.
Yes, LLYC dividends are paid quarterly. The last dividend per share was 1.34 EUR. As of today, Dividend Yield (TTM)% is 0.75%. Tracking ELI LILLY CO dividends might help you take more informed decisions.
ELI LILLY CO dividend yield was 0.67% in 2024, and payout ratio reached 44.39%. The year before the numbers were 0.78% and 77.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 29, 2025, the company has 47 K employees. See our rating of the largest employees — is ELI LILLY CO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ELI LILLY CO EBITDA is 19.92 B EUR, and current EBITDA margin is 41.75%. See more stats in ELI LILLY CO financial statements.
Like other stocks, LLYC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ELI LILLY CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ELI LILLY CO technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ELI LILLY CO stock shows the sell signal. See more of ELI LILLY CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.